Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSQN.L Regulatory News (SQN)

  • There is currently no data for SQN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Anaerobic Digestion Assets

20 Jan 2020 08:26

RNS Number : 2893A
SQN Asset Finance Income Fund Ltd
20 January 2020
 

20 January 2020

 

SQN Asset Finance Income Fund Limited

 

Anaerobic Digestion Assets

 

SQN Asset Finance Income Fund Limited (the "Company") has invested in a total of 15 Anaerobic Digestion ("AD") plants since its launch. Four have subsequently been exited profitably and 11 remain in the ordinary share portfolio.

 

At the time of the publication of the Annual Report and Accounts for the year ended 30 June 2019, which were released on 30 September 2019, the Company reported all of the AD plants had completed construction and that six were in the ramp-up phase which often involves continuous refinement until the plants reach optimum output. As reported in the results, this process has proven to take longer than anticipated and occasionally requires additional capital which can affect the overall economics of the investments. This led the Company to make an impairment at that time of £3.2 million across two of these AD plants.  

 

In preparation for the review of the interim accounts for the six months ended 31 December 2019, the Company is undertaking a review of the models and projections supporting the carrying values of the AD plants. Three of the AD plants have not yet reached targeted operational capacity. A further three AD plants are performing at or above the targeted operational capacity but feedstock costs have been higher than originally anticipated.

 

As a result, the Investment Manager has undertaken an assessment of the valuation of these assets. Given the large number of variables and the high degree of sensitivity of each of those variables when modelled over the more than 20 year lives of the assets, the range of potential values is large. If the range of values were to be accepted and deemed appropriate for purposes of the interim accounts, a potential impairment of between 4.6 pence to 13.2 pence per ordinary share would have to be recorded. Given the wide range of potential values, and in the interests of prudent risk management, the Board intends to appoint a third-party valuer to provide an independent assessment of the valuation of these assets, which will then be reflected in the 31 December 2019 net asset value ("NAV"). The six assets, in aggregate, had a valuation of £127.7 million, as at 30 November 2019.

 

The C share portfolio has no exposure to AD assets.

 

In light of this ongoing assessment, the publication of the 31 December 2019 NAV for the ordinary shares is expected to be delayed and a further update will be released as soon as possible. The 31 December 2019 NAV for the C shares is expected to be announced later this week.

 

The Investment Manager will continue to work with the asset operators to achieve optimisation of each of the AD plants with the intention of monetising these assets in due course, together with the five AD plants operating in-line with expectations. It should be noted that the four AD plants that have been exited to date have achieved yields of between 11% and 20%, the highest return being on an investment that went into default and required a complicated workout.

 

The Company has a triennial continuation vote, with the next vote to be held at its AGM this year and the Board intends to consult with shareholders in due course.

 

This announcement contains Inside Information as defined under the Market Abuse Regulation (EU) No. 596/2014.

 

LEI: 2138007S3YRY3IUU4W39

 

 

For further information please contact:

 

SQN Capital Management, LLC

Jeremiah Silkowski

Neil Roberts

 

01932 575 888

Winterflood Securities Limited

020 3100 0000

Neil Langford

Chris Mills

 

Buchanan

Charles Ryland

Henry Wilson

020 7466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCZZGZMRGDGGZG
Date   Source Headline
28th Mar 20181:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20187:00 amRNSHalf-year Report
21st Mar 20184:32 pmRNSHolding(s) in Company
21st Mar 201811:04 amRNSHolding(s) in Company
21st Mar 20187:00 amRNSMonthly NAV and Dividend
22nd Feb 20182:24 pmRNSHolding(s) in Company
21st Feb 20187:00 amRNSMonthly NAV, Dividend and Investment Update
13th Feb 201812:28 pmRNSDirector Declaration
5th Feb 20184:56 pmRNSDirector/PDMR Shareholding
2nd Feb 20187:00 amRNSUpdate on Snoozebox Investment
23rd Jan 20184:18 pmRNSHolding(s) in Company
23rd Jan 20189:34 amRNSUpdate on Suniva, Inc - Tariffs to be Implemented
22nd Jan 20187:00 amRNSMonthly Net Asset Value and Dividend
19th Jan 20183:17 pmRNSHolding(s) in Company
12th Jan 20181:49 pmRNSPortfolio Update
27th Dec 20177:00 amRNSDirector Declaration
21st Dec 20177:00 amRNSMonthly NAV, Dividend and Investment Update
20th Dec 20176:00 pmRNSDirectorate Change
21st Nov 20177:00 amRNSMonthly NAV, Dividend and Investment Update
20th Nov 20174:03 pmRNSResult of AGM, GM and Class Meetings
8th Nov 20173:30 pmRNSUpdate on discussions with Snoozebox Holdings plc
24th Oct 201712:00 pmRNSHolding(s) in Company
20th Oct 20177:00 amRNSMonthly NAV and Dividend
18th Oct 20176:00 pmRNSNotices of AGM, GM and Class Meetings
5th Oct 20172:06 pmRNSDirector/PDMR Shareholding
5th Oct 20177:00 amRNSAnnual Financial Report
3rd Oct 20177:00 amRNSNew Website
22nd Sep 20174:37 pmRNSSuccessful Outcome for SQN re Suniva
21st Sep 20177:00 amRNSMonthly NAV and Dividend
21st Aug 20177:00 amRNSMonthly NAV and Dividend Update
18th Aug 20176:00 pmRNSDirectorate Change
21st Jul 20177:00 amRNSMonthly NAV, Dividend and Portfolio Update
21st Jun 20177:00 amRNSMonthly Net Asset Value and Dividend
23rd May 20177:00 amRNSMonthly NAV and Dividend
8th May 20173:18 pmRNSHolding(s) in Company
25th Apr 20177:00 amRNSMonthly NAV and Dividend
19th Apr 201710:40 amRNSPortfolio Update
22nd Mar 20179:44 amRNSHolding(s) in Company
21st Mar 20177:00 amRNSMonthly NAV and Dividend
20th Feb 20177:00 amRNSHalf-year Report
17th Feb 20177:00 amRNSMonthly NAV and Dividend
23rd Jan 20177:00 amRNSMonthly NAV and Dividend
16th Jan 20173:49 pmRNSHolding(s) in Company
3rd Jan 20177:00 amRNSTotal Voting Rights
30th Dec 20167:00 amRNSSubmission Details for TR1 Forms
30th Dec 20167:00 amRNSNon-Mainstream Pooled Investments (NMPIs)
28th Dec 20163:22 pmRNSDirector/PDMR Shareholding
28th Dec 20162:03 pmRNSHolding(s) in Company
28th Dec 20162:01 pmRNSHolding(s) in Company
28th Dec 20161:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.